The projected fair value for Rigel Pharmaceuticals is US$39.77 based on 2 Stage Free Cash Flow to Equity With US$40.87 share price, Rigel Pharmaceuticals appears to be trading close to its estimated ...

Rigel Pharmaceuticals' strategic acquisitions of GAVRETO and REZLIDHIA, along with strong TAVALISSE sales, position the company for significant growth and potential profitability. Despite historical ...

Rigel Pharmaceuticals (RIGL) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue ...

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) shares are on the move Wednesday after the company reported fourth-quarter results well above analyst expectations. What Happened: Rigel reported fourth-quarter ...